3
c
6
7
8
9
CuBr
CuBr
CuBr
CuBr
CuBr
CuBr
CuBr
CuBr
CuBr
K
2
CO
PO
CO
CO
3
DMSO
DMSO
DMSO
DMSO
DMF
120
120
120
120
120
120
80
Trace
K
3
4
57
60
54
17
0
Na
Cs
2
3
2
3
1
0
1
2
3
4
K
2
CO
CO
CO
CO
CO
3
1
1
1
1
K
2
3
Toluene
DMSO
DMSO
DMSO
K
2
3
3
3
20
56
63
K
2
100
140
K
2
a
b
c
Isolated yields.
0 mol% catalyst.
Reaction performed under N
1
Scheme 2. Proposed reaction mechanism for the preparation of 2-substituted
quinazoline-4(3H)-ones
2
.
Acknowledgments
Having obtained the optimized conditions, the formation of 2-
phenylquinazolin-4(3H)-ones was examined using various aryl
and heteroaryl methaneamines, affording products 7a-7k in 66-
This study was funded and supported by the Research Council of
Tehran University of Medical Sciences (TUMS), Grant no. 95-
31
7
7% yield (Table 2).
02-92-32295; and Iran National Science Foundation (INSF).
Table 2. Synthesis of quinazoline-4(3H)-ones 7a-k
Compound Ar
Yield
%)
References and notes
(
7
7
a
C
6
H
5
70
72
73
73
77
74
66
70
68
70
72
1.
(a) Mhaske, S.B.; Argade, N.P. Tetrahedron 2006, 62, 9787-9826;
b) Horton, D.A.; Bourne, G.T.; Smythe, M.L. Chem. Rev. 2003,
03, 893-930.
(a) Lüth, A.; Löwe, W. Eur. J. Med. Chem. 2008, 43, 1478-1488;
b) Cao, S.L.; Feng, Y.P.; Jiang, Y.Y.; Liu, S.Y.; Ding, G.Y.; Li,
R.T. Bioorg. Med. Chem. Lett. 2005, 15, 1915-1917.
Kuarm, B.S.; Reddy, Y.T.; Madhav, J.V.; Crooks, P.A.; Rajitha,
B. Bioorg. Med. Chem. Lett. 2011, 21, 524-527.
(
1
b
2-MeOC
3-MeOC
4-MeOC
6
6
6
H
H
H
4
4
4
2
.
7
c
(
7
d
3
4
.
.
7
e
f
4-Me
2
NC
6
H
4
(a) Lowe, J.A.; Archer, R.L.; Chapin, D.S.; Cheng, J.B.; Helweg,
D.; Johnson, J.L.; Koe , B.K.; Lebel, L.A.; Moore, P.F.; Nielsen, J.
A.; Russo, L.L.; Shirley, J.T. J. Med. Chem. 1991, 34, 624-628;
7
4-MeC
6
H
4
7
7
g
4-FC
6
H
4
(b) Kenichi, O.; Yoshihisa, Y.; Toyonari, O.; Toru, I.; Yoshio, I. J.
h
2-ClC
6
H
4
Med. Chem. 1985, 28, 568-576.
5
.
(a) Aly, M.M.; Mohamed, Y.A.; El-Bayouki, K.A.M.; Basyouni,
W.M.; Abbas, S.Y. Eur. J. Med. Chem. 2010, 45, 3365-3373; (b)
Wolfe, J.F.; Rathman, T.L.; Sleevi, M.C.; Campbell, J.A.;
Greenwood, T.D. J. Med. Chem. 1990, 33, 161-166.
Tereshima, K.; Shimamura, H.; Kawase, A.; Tanaka, Y.;
Tanimura, T.; Kamisaki, T.; Ishizuka, Y.; Sato, M. Chem. Pharm.
Bull. 1995, 43, 2021-2023.
(a) Bedi, P.M.S.; Kumar, V.; Mahajan, M.P. Bioorg. Med. Chem.
Lett. 2004, 14, 5211-5213; (b) Meyyanathan, S.N.; Ramu, M.;
Suresh, B. Med. Chem. Res. 2010, 19, 993-999.
7
7
i
2-O
3-O
2
2
NC
6
6
H
H
4
4
j
NC
7
k
2-thienyl
6
7
8
.
.
.
A suggested mechanism for the formation of quinazoline-
(3H)-ones 7 is depicted in Scheme 2. First, N-substituted
4
anthranilamide 8, prepared through nucleophilic addition of
amine 5 to isatoic anhydride 6, undergoes a copper-catalysed
aerobic oxidation to give the imine intermediate 9. Then,
intramolecular attack of the imine bond and subsequent copper-
catalysed aerobic oxidation led to the formation of quinazoline-
Malamas, M.S.; Millen, J. J. Med. Chem. 1991, 34, 1492-1503.
Li, H.; Huang, R.; Qiu, D.; Yang, Z.; Liu, X.; Ma, J.; Ma, Z. Prog.
Nat. Sci. 1998, 8, 359-365.
9.
1
1
1
1
0. Chandrika, P.M.; Yakaiah, T.; Narsaiah, B.; Sridhar, V.;
Venugopal, G.; Rao, J.V.; Kumar, K.P.; Murthy, U.S.N.; Rao,
A.R.R. Indian J. Chem. 2009, 48, 840-847.
1. (a) Chawla, A.; Batra, C. Int. Res. J. Pharm. 2013, 4, 49-58; (b)
Arora, R.; Kapoor, A.; Gill, N.S.; Rana, A.C. Int. Res. J. Pharm.
4
(3H)-ones 7 (Scheme 2).
In conclusion, we have developed a novel and efficient
2
011, 2, 22-28.
approach for the preparation of quinazoline-4(3H)-ones via the
reaction of isatoic anhydride and (het)arylmethanamines in
DMSO, followed by aerobic oxidation in the presence of CuBr
and K CO at 120 C. Use of commercially available starting
2 3
materials, ligand-free metal catalysis and aerobic oxidative
conditions are the main advantages of this method.
2. (a) Witt, A.; Bergman, J. Curr. Org. Chem. 2003, 7, 659-677; (b)
Mitscher, L.A.; Wong, W.C.; De Meulenere, T.; Sulko, J.; Drake,
S. Heterocycles 1981, 15, 1017-1021.
3. (a) Chatterjee, A.; Ganguly, M. Phytochemistry 1968, 7, 307-311;
(
b) Joshi, B.S.; Newton, M.G.; Lee, D.W.; Barber, A.D.; Pelletier,
S.W. Tetrahedron: Asymmetry 1996, 7, 25-28; (c) Ghosal, S.;
Chauhan, R.B.P.S.; Mehta, R. Phytochemistry 1975, 14, 830-832.
4. Koepfli, J.B.; Mead, J.F.; Brockman, J.A. J. Am. Chem. Soc. 1947,
1
1
1
1
1
6
9, 1837-1837.
5. Kobayashi, S.; Ueno, M.; Suzuki, R.; Ishitani, H. Tetrahedron
Lett. 1999, 40, 2175-2178.
6. Mekala, R.; Akula, R.; Kamaraju, R.R.; Bannoth, C.K.; Regati, S.;
Sarva, J. Synlett, 2014, 25, 821-826.
7. Wei, H.; Li, T.; Zhou, Y.; Zhou, L.; Zeng, Q. Synthesis, 2013, 45,
3
349-3354.
8. Cheng, R.; Guo, T.; Zhang-Negrerie, D.; Du, Y.; Zhao, K.
Synthesis, 2013, 45, 2998-3006.